The DCE parameters including Ktrans and Ve have been used to assess glioblastoma treatment responses reflecting tumor cellularity and tumor vasculature. We hypothesized that the enhancement pattern of the ionic macrocyclic contrast agent used in glioblastoma DCE study, which interacts with the negative charge on the surface of the tumor cell, was different from that of the nonionic one. We demonstrated it with prospective DCE experiments using the orthotopic glioblastoma models as well as Ktrans and Ve from ionic were more correlated with tumor pathology than nonionic. These findings may aid clinical choice of GBCA in DCE-MRI study.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords